Ampio Pharmaceuticals

AMPE · OTC

$0.1831−$0.4569 (−71.39%)TodayMarket closed · May 8, 10:35 AM ET

No price history for this range.

About AMPE

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Englewood, Colorado and currently employs 6 full-time employees. The company went IPO on 2011-05-19. The firm is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Employees: 6
Headquarters: Englewood, Colorado
Listed: May 19, 2011
Sector: Health Care
Industry: Pharmaceuticals
Website: ampiopharma.com

Leadership

Ampio Pharmaceuticals executives
Name	Title	Since	Age
J. Kevin Buchi	—	—	70
Michael Martino	—	2021	68
Daniel Stokely	—	—	60
Elizabeth Jobes	—	—	58
David Stevens	—	—	74

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Ampio Pharmaceuticals suppliers and customers
Company	Relationship	Country	Correlation
Sartorius Vz SRT3.DE	Supplier	DE	0.64
Thermo Fisher Scientific TMO	Supplier	US	-0.14
Afton Scientific, LLC	Supplier	US	—
NOVA Biologics, Inc.	Supplier	US	—
Philadelphia Trading, Inc.	Supplier and customer	US	—
Octapharma AG	Supplier	CH	—

Similar companies

Companies in the same industry as Ampio Pharmaceuticals

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.